Inhibition of Nitric Oxide Synthetase at Mid-gestation in Rats is Associated With Increases in Arterial Pressure, Serum Tumor Necrosis Factor- , and Placental Apoptosis
Author(s) -
Kiyomi Tsukimori,
Hideo Komatsu,
Kotaro Fukushima,
Tsunehisa Kaku,
Hideki Nakano,
Norio Wake
Publication year - 2008
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2007.80
Subject(s) - preeclampsia , medicine , placentation , gestation , blood pressure , endocrinology , trophoblast , placenta , nitric oxide , pregnancy , saline , mean arterial pressure , tumor necrosis factor alpha , nitric oxide synthase , andrology , fetus , biology , heart rate , genetics
Reduced uteroplacental perfusion and maternal cardiovascular dysfunction have been considered to be the main pathophysiological features of preeclampsia. In order to determine whether inhibition of nitric oxide synthetase (NOS) during the initial stage of placentation is associated with impaired placental development and maternal cardiovascular dysfunction, we studied the effect of N-nitro-arginine methyl ester (L-NAME), a NOS inhibitor, on morphological changes in the placenta, maternal blood pressure, and serum tumor necrosis factor-alpha (TNF-alpha) in pregnant rats during the initial stage of placentation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom